What the company does
Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compounding Services. The company's products include DiluCap, a line of excipients to compound every capsule formulation; DiluTab, for Cardiology and Primary care application; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders, such as vitiligo; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of …
What the weekly tape is saying
FAGR closed the latest completed week at 24.75 EUR. The 4-week return is 3.3% and the 12-week return is 16.2%. Trend Signal is active, Market Dynamics is 0.88. Setup signature: Balanced read with a 64/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 22.27 EUR
- Vs Trend Line
- 11.1%
- Fair Value
- 18.75 EUR
- Vs Fair Value
- 32.0%
- 52W High
- 25.30 EUR
- 52W Low
- 18.92 EUR
- Drawdown
- -2.2%
- Range Position
- 91.4%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 21 weeks
- 52W Active Weeks
- 34
- 52W Active Breadth
- 65.4%
- Sector Scope
- BE Healthcare
- Sector Rank
- 3 of 12
- Sector Percentile
- 81.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
BE Healthcare
- Tracked Peers
- 12
- 4W Rank
- 5 of 12
- Avg 1W
- -3.8%
- Avg 4W
- -1.8%
- Trend Breadth
- 33.3%
- Positive MD
- 41.7%
BE Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 1
- 4W Rank
- 1 of 1
- Avg 1W
- 4.7%
- Avg 4W
- 3.3%
- Trend Breadth
- 100.0%
- Positive RS
- 100.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.88
- 4W MD Change
- 44.6%
- Relative Strength
- 1.04
- 4W RS Change
- -43.4%
- Expectation
- Undecided
- Probability
- 53.36%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 439.1K
- 13W Average
- 552.5K
- 52W Average
- 430.1K
- Vs 13W
- 0.8x
- Vs 52W
- 1.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 3.6%
- 52W Volatility
- 2.7%
- Upside Weeks
- 27
- Downside Weeks
- 24
- Downside Breadth
- 46.2%
- Avg Gain / Loss
- 2.4% / -2.0%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- BRU
- Country
- BE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- EUR
- Market Cap
- 1.7B
Opportunity signals
- Trend Signal is active with a 21-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- No major top-level risk cluster is currently dominant.
Watch next
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 24.75 EUR | 4.7% | 22.27 EUR | 18.75 EUR | 0.88 | 1.04 | 439.1K | On |
| 5 Jun 2026 | 23.65 EUR | -1.9% | 22.13 EUR | 18.68 EUR | 0.92 | -0.95 | 478.8K | On |
| 29 May 2026 | 24.10 EUR | -3.6% | 22.01 EUR | 18.63 EUR | 1.05 | 0.61 | 526.4K | On |
| 22 May 2026 | 25.00 EUR | 4.4% | 21.89 EUR | 18.58 EUR | 0.92 | 4.06 | 551.4K | On |
| 15 May 2026 | 23.95 EUR | -1.0% | 21.73 EUR | 18.52 EUR | 0.61 | 1.83 | 635.8K | On |
| 8 May 2026 | 24.20 EUR | 2.5% | 21.61 EUR | 18.47 EUR | 0.62 | 2.83 | 445.0K | On |
| 1 May 2026 | 23.61 EUR | 1.7% | 21.49 EUR | 18.42 EUR | 0.42 | 2.27 | 365.2K | On |
| 24 Apr 2026 | 23.21 EUR | -3.3% | 21.37 EUR | 18.37 EUR | 0.24 | 0.69 | 438.8K | On |
| 17 Apr 2026 | 24.00 EUR | 8.4% | 21.24 EUR | 18.33 EUR | 0.03 | -0.18 | 933.0K | On |
| 10 Apr 2026 | 22.13 EUR | 1.8% | 21.09 EUR | 18.28 EUR | -0.31 | -6.05 | 732.9K | On |
| 3 Apr 2026 | 21.74 EUR | 4.2% | 21.03 EUR | 18.24 EUR | -0.33 | -3.74 | 528.1K | On |
| 27 Mar 2026 | 20.85 EUR | -2.1% | 21.00 EUR | 18.20 EUR | -0.23 | -3.50 | 544.7K | On |
| 20 Mar 2026 | 21.29 EUR | -2.7% | 20.98 EUR | 18.16 EUR | 0.24 | -0.09 | 563.6K | On |
| 13 Mar 2026 | 21.88 EUR | 2.3% | 20.95 EUR | 18.11 EUR | 0.51 | -1.11 | 386.9K | On |